An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

Influenza prevention with the cell-based quadrivalent vaccine (QIVc) was superior to the egg-based vaccine (QIVe) during the US 2022–2023 flu season.

The prospect of the worrisome triple threat of COVID, RSV and flu was assuaged last year by the effectiveness of flu vaccines. Two recent studies from the Centers for Disease Control and Prevention's ...

A quadrivalent nucleoside-modified messenger RNA influenza vaccine met superiority criteria compared with a licensed inactivated vaccine.

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, with this version being a nasal spray as opposed to an injection. The ...

An ongoing outbreak of highly pathogenic avian influenza has affected more than 184 million domestic poultry since 2022 and, ...

The prospect of the worrisome triple threat of COVID, RSV and flu was assuaged last year by the effectiveness of flu vaccines. Two recent studies from the Centers for Disease Control and Prevention’s ...